中国P站

E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Neuroinfect Dis 2025, Vol 16(5): 5

Autoimmune Encephalitis: Diagnosis, Treatment, and Prognosis

Thomas Berger*
Dept. of Neurology, Vienna Medical University, Austria
*Corresponding Author : Thomas Berger, Dept. of Neurology, Vienna Medical University, Austria, Email: t.berger@meduni.at

Received Date: Sep 02, 2025 / Published Date: Sep 30, 2025

Abstract

Autoimmune encephalitis (AE) comprises inflammatory brain disorders characterized by autoantibodies targeting neuronal anti
gens, leading to varied neurological symptoms. Early diagnosis and immunotherapy are crucial for favorable prognoses. Advances in
identifying autoantibodies, including those against intracellular targets, have refined understanding and treatment strategies. Diagnos
tic approaches integrate clinical findings, CSF analysis, autoantibody testing, and neuroimaging. Treatment involves immunomod
ulatory therapies such as corticosteroids, IVIg, and plasma exchange, with second-line options for refractory cases. Anti-NMDA
receptor encephalitis is a prevalent subtype, and paraneoplastic AE is linked to underlying cancers. Prognosis varies, emphasizing
ongoing research in neurorehabilitation and understanding predictors of recovery

Citation: 脗聽Berger T (2025) Autoimmune Encephalitis: Diagnosis, Treatment, and Prognosis. JNID 16: 584.

Copyright: 漏 2025 Thomas Berger This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted聽use, distribution and reproduction in any medium, provided the original author and source are credited.

International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.